Masaryk Memorial Cancer Institute
🇨🇿Czech Republic
- Country
- 🇨🇿Czech Republic
- Ownership
- Private
- Established
- 1935-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.mou.cz
Clinical Trials
7
Active:2
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (71.4%)Phase 1
1 (14.3%)Phase 2
1 (14.3%)Pancreatic Cancer Screening in a Population at High Risk
Not Applicable
Recruiting
- Conditions
- Pancreatic Ductal AdenocarcinomaHereditary DiseasesPancreatitis, Chronic
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Masaryk Memorial Cancer Institute
- Target Recruit Count
- 700
- Registration Number
- NCT06330441
- Locations
- 🇨🇿
Masaryk Memorial Cancer Institute, Brno, Czechia
Optimization of Fractionation Schedules of Heel Spur Radiotherapy Prospective Randomized Open-label Trial
Not Applicable
Recruiting
- Conditions
- Heel Spur
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Masaryk Memorial Cancer Institute
- Target Recruit Count
- 430
- Registration Number
- NCT06104410
- Locations
- 🇨🇿
Masaryk Memorial Cancer Institute, Brno, Czechia
Adjuvant Partial-breast Irradiation Using Stereotactic Body Radiation Therapy
Not Applicable
Completed
- Conditions
- Early-stage Breast Cancer
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- Masaryk Memorial Cancer Institute
- Target Recruit Count
- 85
- Registration Number
- NCT06007118
- Locations
- 🇨🇿
Masaryk Memorial Cancer Institute, Brno, Czech Republic, Czechia
11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
Phase 2
Active, not recruiting
- Conditions
- Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Masaryk Memorial Cancer Institute
- Target Recruit Count
- 71
- Registration Number
- NCT05608395
- Locations
- 🇨🇿
Masaryk Memorial Cancer Institute, Brno, Czech Republic, Czechia
Prostate Cancer Screening With Abbreviated MRI Protocol
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Masaryk Memorial Cancer Institute
- Target Recruit Count
- 300
- Registration Number
- NCT05603351
- Locations
- 🇨🇿
Masaryk Memorial Cancer Institute, Brno, Czech Republic, Czechia
- Prev
- 1
- 2
- Next
News
No news found